Search Results - "KRÖGER, Nicolaus"

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years by Passweg, Jakob R., Baldomero, Helen, Chabannon, Christian, Basak, Grzegorz W., de la Cámara, Rafael, Corbacioglu, Selim, Dolstra, Harry, Duarte, Rafael, Glass, Bertram, Greco, Raffaella, Lankester, Arjan C., Mohty, Mohamad, Peffault de Latour, Régis, Snowden, John A., Yakoub-Agha, Ibrahim, Kröger, Nicolaus

“…Numbers of Hematopoietic cell transplantation (HCT) in Europe and collaborating countries continues to rise with 48,512 HCT in 43,581 patients, comprising of…”
Get full text

Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend "when and for whom" in 2021? by Gagelmann, Nico, Kröger, Nicolaus

“…Allogeneic hematopoietic stem-cell transplantation is a potentially curative therapy for various hematologic diseases. An essential component of this procedure…”
Get full text

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus by Passweg, Jakob R., Baldomero, Helen, Chabannon, Christian, Basak, Grzegorz W., Corbacioglu, Selim, Duarte, Rafael, Dolstra, Harry, Lankester, Arjan C., Mohty, Mohamad, Montoto, Silvia, Peffault de Latour, Régis, Snowden, John A., Styczynski, Jan, Yakoub-Agha, Ibrahim, Kröger, Nicolaus

“…Hematopoietic-cell transplantation (HCT) is widely used for acquired and congenital disorders of the hematopoietic system. Number of transplants performed in…”
Get full text

Reply to Shao and Zhou by Gagelmann, Nico, Kröger, Nicolaus

Get full text

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease by Kröger, Nicolaus, Solano, Carlos, Wolschke, Christine, Bandini, Giuseppe, Patriarca, Francesca, Pini, Massimo, Nagler, Arnon, Selleri, Carmine, Risitano, Antonio, Messina, Giuseppe, Bethge, Wolfgang, Pérez de Oteiza, Jaime, Duarte, Rafael, Carella, Angelo Michele, Cimminiello, Michele, Guidi, Stefano, Finke, Jürgen, Mordini, Nicola, Ferra, Christelle, Sierra, Jorge, Russo, Domenico, Petrini, Mario, Milone, Giuseppe, Benedetti, Fabio, Heinzelmann, Marion, Pastore, Domenico, Jurado, Manuel, Terruzzi, Elisabetta, Narni, Franco, Völp, Andreas, Ayuk, Francis, Ruutu, Tapani, Bonifazi, Francesca

“…Antilymphocyte globulin (ATG) added to the conditioning regimen before allogeneic hematopoietic stem-cell transplantation resulted in a lower rate of chronic…”
Get full text

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies by Passweg, Jakob R., Baldomero, Helen, Basak, Grzegorz W., Chabannon, Christian, Corbacioglu, Selim, Duarte, Rafael, Kuball, Jürgen, Lankester, Arjan, Montoto, Silvia, de Latour, Régis Peffault, Snowden, John A., Styczynski, Jan, Yakoub-Agha, Ibrahim, Arat, Mutlu, Mohty, Mohamad, Kröger, Nicolaus

“…Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the hematopoietic system. Number of transplants done in Europe…”
Get full text

Development of CAR-T cell therapies for multiple myeloma by Gagelmann, Nico, Riecken, Kristoffer, Wolschke, Christine, Berger, Carolina, Ayuk, Francis A., Fehse, Boris, Kröger, Nicolaus

“…Currently available data on chimeric antigen receptor (CAR)-T cell therapy has demonstrated efficacy and manageable toxicity in heavily pretreated multiple…”
Get full text

Steroid-refractory chronic graft-versus-host disease: treatment options and patient management by Wolff, Daniel, Fatobene, Giancarlo, Rocha, Vanderson, Kröger, Nicolaus, Flowers, Mary E.

“…Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation…”
Get full text

Graft-versus-host disease in allogeneic transplantation: the good and the bad by Kröger, Nicolaus-Martin

Get full text

Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel by Bonifazi, Francesca, Rubio, Marie-Thérèse, Bacigalupo, Andrea, Boelens, Jaap Jan, Finke, Jürgen, Greinix, Hildegard, Mohty, Mohamad, Nagler, Arnon, Passweg, Jakob, Rambaldi, Alessandro, Socie, Gérard, Solano, Carlos, Walker, Irwin, Barosi, Giovanni, Kröger, Nicolaus

“…This collaborative initiative aimed to provide recommendations on the use of polyclonal antithymocyte globulin (ATG) or anti-T lymphocyte globulin (ATLG) for…”
Get full text

Improving allogeneic stem cell transplantation in myelofibrosis by Gagelmann, Nico, Kröger, Nicolaus

“…In this review, we will outline dimensions in which outcome of patients with myelofibrosis undergoing curative treatment can be optimized: patient selection,…”
Get full text

CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT by Schmidt-Hieber, Martin, Labopin, Myriam, Beelen, Dietrich, Volin, Liisa, Ehninger, Gerhard, Finke, Jürgen, Socié, Gerard, Schwerdtfeger, Rainer, Kröger, Nicolaus, Ganser, Arnold, Niederwieser, Dietger, Polge, Emmanuelle, Blau, Igor W., Mohty, Mohamad

“…We analyzed the prognostic impact of donor and recipient cytomegalovirus (CMV) serostatus in 16 628 de novo acute leukemia patients after allogeneic stem cell…”
Get full text

Evaluation of the Robustness of Therapeutic Drug Monitoring Coupled with Bayesian Forecasting of Busulfan with Regard to Inaccurate Documentation by Dadkhah, Adrin, Alihodzic, Dzenefa, Broeker, Astrid, Kröger, Nicolaus, Langebrake, Claudia, Wicha, Sebastian G.

“…Background Inaccurate documentation of sampling and infusion times is a potential source of error in personalizing busulfan doses using therapeutic drug…”
Get full text

Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation by Gagelmann, Nico, Ditschkowski, Markus, Bogdanov, Rashit, Bredin, Swann, Robin, Marie, Cassinat, Bruno, Shahswar, Rabia, Thol, Felicitas, Heuser, Michael, Socié, Gerard, Beelen, Dietrich, Triviai, Ioanna, Badbaran, Anita, Kröger, Nicolaus

“…Allogeneic hematopoietic stem cell transplantation is curative in myelofibrosis, and current prognostic scoring systems aim to select patients for…”
Get full text

Allogeneic stem cell transplantation to cure hematological malignancies by Kröger, Nicolaus

Get full text

Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis by Shouval, Roni, Fein, Joshua A, Labopin, Myriam, Kröger, Nicolaus, Duarte, Rafael F, Bader, Peter, Chabannon, Christian, Kuball, Jurgen, Basak, Grzegorz Wladyslaw, Dufour, Carlo, Galimard, Jacques-Emmanuel, Polge, Emmanuelle, Lankester, Arjan, Montoto, Silvia, Snowden, John A, Styczynski, Jan, Yakoub-Agha, Ibrahim, Mohty, Mohamad, Nagler, Arnon

“…The introduction of donors other than HLA-matched siblings has been a pivotal change in stem cell transplantation. We aimed to assess the evolution of outcomes…”
Get full text

Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation by Massoud, Radwan, Gagelmann, Nico, Fritzsche-Friedland, Ulrike, Zeck, Gaby, Heidenreich, Silke, Wolschke, Christine, Ayuk, Francis, Christopeit, Maximilian, Kröger, Nicolaus

“…Anti-T-cell lymphocyte globulin (ATLG) and posttransplant cyclophosphamide (PTCy) are now widely used strategies to prevent graft-versus-host disease (GVHD)…”
Get full text

The role of novel agents for consolidation after autologous transplantation in newly diagnosed multiple myeloma: a systematic review by Gagelmann, Nico, Kröger, Nicolaus

“…Despite the increasing inclusion of novel agents within the multiple myeloma (MM) treatment sequence, their role for posttransplant consolidation therapy…”
Get full text

Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation by Battipaglia, Giorgia, Labopin, Myriam, Kröger, Nicolaus, Vitek, Antonin, Afanasyev, Boris, Hilgendorf, Inken, Schetelig, Johannes, Ganser, Arnold, Blaise, Didier, Itälä-Remes, Maija, Passweg, Jakob R., Bonifazi, Francesca, Finke, Jurgen, Ruggeri, Annalisa, Nagler, Arnon, Mohty, Mohamad

“…The use of anti-thymocyte globulin (ATG) has represented the standard of care in graft-versus-host disease (GVHD) prophylaxis in patients undergoing a…”
Get full text

Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019 by Duarte, Rafael F., Labopin, Myriam, Bader, Peter, Basak, Grzegorz W., Bonini, Chiara, Chabannon, Christian, Corbacioglu, Selim, Dreger, Peter, Dufour, Carlo, Gennery, Andrew R., Kuball, Jürgen, Lankester, Arjan C., Lanza, Francesco, Montoto, Silvia, Nagler, Arnon, Peffault de Latour, Régis, Snowden, John A., Styczynski, Jan, Yakoub-Agha, Ibrahim, Kröger, Nicolaus, Mohty, Mohamad

“…This is the seventh special EBMT report on the indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune…”
Get full text